- Home
- RLMD vs SWIM Comparison
RLMD vs SWIM Comparison
Compare RLMD & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLMD | SWIM |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 777.2M | 695.9M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RLMD | SWIM |
|---|---|---|
| Price | $7.40 | $5.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $12.40 | $6.75 |
| AVG Volume (30 Days) | ★ 1.1M | 539.8K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.28 | ★ 160.00 |
| EPS | N/A | ★ N/A |
| Revenue | $13,070.00 | ★ $545,912,000.00 |
| Revenue This Year | N/A | $10.95 |
| Revenue Next Year | N/A | $6.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 154.83 | 7.35 |
| 52 Week Low | $0.44 | $5.04 |
| 52 Week High | $8.00 | $8.97 |
Technical Indicators
Market Signals| Indicator | RLMD | SWIM |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 29.71 |
| Support Level | $6.81 | $5.04 |
| Resistance Level | $7.94 | $6.81 |
| Average True Range (ATR) | 0.42 | 0.27 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 51.79 | 0.44 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. The company derives a majority of its revenue from the United States.